[1] Technical Guidance Group of the Fifth National TB Epidemiological Survey, the Office of the Fifth National TB Epidemiological. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antitub 2012;34(8):485 − 508. (In Chinese). 
[2] Li RZ, Ruan YZ, Sun Q, Wang XX, Chen MT, Zhang YL, et al. Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study. Lancet Glob Health 2015;3(4):e217 − 28. http://dx.doi.org/10.1016/S2214-109X(15)70021-5CrossRef
[3] Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 2014;11(7):e1001675. http://dx.doi.org/10.1371/journal.pmed.1001675CrossRef
[4] Commision NH. Healthy China initiative (2019-2030). 2019. http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm. [2019-07-15]. (In Chinese). http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm
[5] Commission NH, Commission NDaR, Education Mo, et al. Action plan to stop TB (2019-2022). 2019. http://www.gov.cn/gongbao/content/2019/content_5437149.htm. [2019-05-31]. (In Chinese). http://www.gov.cn/gongbao/content/2019/content_5437149.htm
[6] Council OotS. “Thirteenth Five-Year Plan” National TB Control Programme. 2017. http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm. [2017-02-01]. (In Chinese). http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm
[7] Jiang WX, Long Q, Lucas H, Dong D, Chen JY, Xiang L, et al. Impact of an innovative financing and payment model on tuberculosis patients' financial burden: is tuberculosis care more affordable for the poor?. Infect Dis Poverty 2019;8(1):21. http://dx.doi.org/10.1186/s40249-019-0532-xCrossRef
[8] Zhou CC, Long Q, Chen JY, Xiang L, Li Q, Tang SL, et al. Factors that determine catastrophic expenditure for tuberculosis care: a patient survey in China. Infect Dis Poverty 2016;5:6. http://dx.doi.org/10.1186/s40249-016-0100-6CrossRef
[9] Yip WCM, Hsiao WC, Chen W, Hu SL, Ma J, Maynard A. Early appraisal of China’s huge and complex health-care reforms. Lancet 2012;379(9818):833 − 42. http://dx.doi.org/10.1016/S0140-6736(11)61880-1CrossRef
[10] Oh KH, Rahevar K, Nishikiori N, Viney K, Choi H, Biermann O, et al. Action towards universal health coverage and social protection for tuberculosis care and prevention: workshop on the end TB strategy pillar 2 in the western pacific region 2017. Trop Med Infect Dis 2018;4(1):3. http://dx.doi.org/10.3390/tropicalmed4010003CrossRef
[11] Pedrazzoli D, Siroka A, Boccia D, Bonsu F, Nartey K, Houben R, et al. How affordable is TB care? Findings from a nationwide TB patient cost survey in Ghana. Trop Med Int Health 2018;23(8):870 − 8. http://dx.doi.org/10.1111/tmi.13085CrossRef
[12] Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J 2014;43(6):1763 − 75. http://dx.doi.org/10.1183/09031936.00193413CrossRef